Table 4.
Comparison of baseline and post-TACE 1 parameters (n = 20)
| Variable, median (IQR) | Baseline, n = 20 | Post-TACE 1, n = 20 | Delta | P value |
| 13C-MBT, μg/kg/hr | 275 (163 to 371) | 253 (124 to 386) | −0.50 (−60.00 to 73.25) | 0.952 |
| ALBI score | −2.12 (−2.52 to −1.55) | −2.09 (−2.51 to −1.41)a | −0.19 (−0.40 to 0.12)a | 0.027 |
| MELD score | 11 (7 to 13) | 11 (7 to 15) | −1.00 (−2.00 to 0.00) | 0.024 |
| Child-Pugh score | 6 (5 to 7) | 6 (5 to 8)a | 0.00 (−1.00 to 0.00)a | 0.289 |
| Bilirubin, mg/dL | 1.15 (0.80 to 2.14) | 0.95 (0.70 to 2.68) | −0.09 (−0.40 to 0.38) | 0.823 |
| Albumin, g/L | 35 (30 to 38) | 33 (30 to 38)a | 2.00 (−1.25 to 5.00)a | 0.037 |
| INR | 1.10 (1.10 to 1.30) | 1.20 (1.00 to 1.38) | −0.05 (−0.10 to 0.00) | 0.181 |
| Creatinine, mg/dL | 0.90 (0.73 to 1.34) | 0.95 (0.75 to 1.19) | −0.02 (−0.14 to 0.08) | 0.908 |
| CRP, mg/L | 8.85 (2.15 to 17.00) | 14.50 (10.00 to 25.00) | −7.50 (−18.85 to 0.25) | 0.012 |
| AFP, ng/mL | 31.00 (4.28 to 570.25) | 36.00 (3.80 to 85.00)b | 0.10 (−7.70 to 123.00)b | 0.646 |
P values < 0.05 are marked in bold.
13C-MBT, 13C-methacetin breath test; AFP, alpha-fetoprotein; ALBI, albumin-bilirubin; CRP, C-reactive protein; INR, international normalized ratio; IQR, interquartile range; MELD, Model for End-Stage Liver Disease; TACE, transarterial chemoembolization.
a
Values of 2 patients missing.
b
Values of 1 patient missing.